Valvoline Inc. to Report Financial Results for Third Quarter 2026 and Host Webcast on August 5

LEXINGTON, Ky.--(BUSINESS WIRE)-- Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in preventive automotive maintenance, today announced that it plans to report financial results for its fiscal third quarter on August 5, 2026. A live audio webcast with analysts and investors will also be held on August 5, 2026 at 9 a.m. ET.

The webcast and slide presentation will be available on the company’s Investor Relations website at http://investors.valvoline.com. Shortly after the call concludes, a replay of the webcast will be available on this same website.

About Valvoline Inc.

Valvoline Inc. (NYSE: VVV) delivers quick, easy, trusted service at more than 2,400 franchised and company-operated service centers across the United States and Canada. The Company completes more than 30 million services annually system-wide, from about 15-minute stay-in-your-car oil changes to a variety of manufacturer-recommended maintenance services such as wiper replacements and tire rotations. At Valvoline Inc., it all starts with our people, including the 13,000 team members who are working to drive the full potential of our core business, deliver sustainable network growth and innovate to meet the evolving needs of our customers and the car parc. For more information, visit vioc.com.

TM Trademark, Valvoline Inc., or its subsidiaries, registered in various countries

View source version on businesswire.com: https://www.businesswire.com/news/home/20260720393905/en/

FOR FURTHER INFORMATION
Investor Relations
Elizabeth B. Clevinger
+1 (859) 357-3155
[email protected]

Media Relations
Angela Davied
+1 (913) 302-0032
[email protected]

Source: Valvoline Inc.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy- Back Programme
• Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients Aged 6 Years and Older